These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38164628)

  • 1. Advances in the management of pancreatic cancer.
    Del Chiaro M; Sugawara T; Karam SD; Messersmith WA
    BMJ; 2023 Dec; 383():e073995. PubMed ID: 38164628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of surgery in pancreatic cancer.
    Buanes TA
    World J Gastroenterol; 2017 Jun; 23(21):3765-3770. PubMed ID: 28638216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of neoadjuvant therapy in pancreatic cancer: a review.
    Russo S; Ammori J; Eads J; Dorth J
    Future Oncol; 2016 Mar; 12(5):669-85. PubMed ID: 26880384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined-modality therapy in pancreatic cancer: current status and future directions.
    McGinn CJ; Zalupski MM
    Cancer J; 2001; 7(4):338-48. PubMed ID: 11561609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy for pancreatic cancer: current status and future directions.
    Xiong HQ; Abbruzzese JL
    Surg Oncol Clin N Am; 2004 Oct; 13(4):737-49, xi. PubMed ID: 15350945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status and future directions in the perioperative treatment of pancreatic cancer.
    Wagener DJ; Punt CJ; Wilke H
    Ann Oncol; 1994; 5 Suppl 3():87-90. PubMed ID: 8204535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant therapy for pancreas cancer in an era of value based cancer care.
    Ahn DH; Williams TM; Goldstein DA; El-Rayes B; Bekaii-Saab T
    Cancer Treat Rev; 2016 Jan; 42():10-7. PubMed ID: 26620819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant therapy for pancreas cancer: advances and controversies.
    Mulcahy MF
    Semin Oncol; 2007 Aug; 34(4):321-6. PubMed ID: 17674960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic advances in pancreatic cancer.
    Paulson AS; Tran Cao HS; Tempero MA; Lowy AM
    Gastroenterology; 2013 Jun; 144(6):1316-26. PubMed ID: 23622141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer.
    Wanebo HJ; Glicksman AS; Vezeridis MP; Clark J; Tibbetts L; Koness RJ; Levy A
    Arch Surg; 2000 Jan; 135(1):81-7; discussion 88. PubMed ID: 10636353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of multimodal treatment for patients with resectable carcinoma of the pancreas.
    Okabayashi T; Nishimori I; Nishioka A; Yamashita K; Sugimoto T; Dabanaka K; Maeda H; Kohsaki T; Ogawa Y; Kobayashi M; Onishi S; Hanazaki K
    Oncol Rep; 2008 Sep; 20(3):651-6. PubMed ID: 18695919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and future strategies for combined-modality therapy in pancreatic cancer.
    Ko AH; Tempero MA
    Curr Oncol Rep; 2002 May; 4(3):202-12. PubMed ID: 11937010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research.
    Buanes TA
    World J Gastroenterol; 2016 Dec; 22(48):10502-10511. PubMed ID: 28082802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulinoma: a review of current management.
    Bliss RD; Carter PB; Lennard TW
    Surg Oncol; 1997; 6(1):49-59. PubMed ID: 9364660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Selection of methods for diagnosis and treatment of pancreatic cancer].
    Ozaki H; Kinoshita T; Kosuge T; Shimada K; Yamamoto J; Inoue K
    Gan To Kagaku Ryoho; 1992 Dec; 19(14):2311-8. PubMed ID: 1463336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival after combined modality therapy for pancreatic cancer.
    Bruckner HW; Kalnicki S; Dalton J; Snady H; Schwartz GK; Chesser MR; Lehrer D; Mandeli J; Harpaz N; Janus C
    J Clin Gastroenterol; 1993 Apr; 16(3):199-203. PubMed ID: 8505490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) - study protocol for a national multicentre randomized controlled trial.
    Labori KJ; Lassen K; Hoem D; Grønbech JE; Søreide JA; Mortensen K; Smaaland R; Sorbye H; Verbeke C; Dueland S
    BMC Surg; 2017 Aug; 17(1):94. PubMed ID: 28841916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival Trends for Resectable Pancreatic Cancer Using a Multidisciplinary Conference: the Impact of Post-operative Chemotherapy.
    Syed AR; Carleton NM; Horne Z; Dhawan A; Bedi G; Kochhar G; Morrissey S; Williams H; Atkinson D; Schiffman S; Monga D; Lupetin A; Kirichenko A; Mitre M; Dhawan M; Kulkarni A; Thakkar S
    J Gastrointest Cancer; 2020 Sep; 51(3):836-843. PubMed ID: 31605289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.
    McGuigan A; Kelly P; Turkington RC; Jones C; Coleman HG; McCain RS
    World J Gastroenterol; 2018 Nov; 24(43):4846-4861. PubMed ID: 30487695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.